T1	Participants 307 343	men at high risk for prostate cancer
T2	Participants 868 1002	3547 individuals were prescreened with 94% (n=3092) determined to be ineligible based on diagnosis of cancer or benign biopsy results.
T3	Participants 1211 1328	Ninety-four (94) subjects consented to participate with 34% of these subjects (n=74) meeting all eligibility criteria